Breaking News

Quantoom Biosciences Installs First Ntensify System for mRNA Manufacturing

The collaboration will facilitate the development of the first African-owned mRNA COVID-19 vaccine.

Quantoom Biosciences S.A., a Univercells company, announced the successful installation of the first Ntensify midi system for mRNA manufacturing at Afrigen Biologics in Cape Town, South Africa. This marks a significant milestone on Quantoom’s efforts to change the way mRNA is manufactured. Within the framework of the mRNA technology transfer program driven by the World Health Organization (WHO), Quantoom has been chosen by Afrigen as the technology partner for the second-generation process an...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters